1477 related articles for article (PubMed ID: 8631596)
1. Interleukin 1 (IL-1) production is not essential for acquired resistance of human A375 melanoma cells to anti-proliferative effect of IL-1.
Itoh S; Hayashi H; Watanabe N; Kobayashi Y; Takii T; Onozaki K
Int J Cancer; 1996 Mar; 65(6):805-11. PubMed ID: 8631596
[TBL] [Abstract][Full Text] [Related]
2. Acquired resistance to the anti-proliferative effect of interleukin-1 and interleukin-6 is a recessive phenotype in A375 human melanoma cells.
Itoh S; Hayashi H; Yang D; Takii T; Onozaki K
Melanoma Res; 1997 Dec; 7(6):455-62. PubMed ID: 9464617
[TBL] [Abstract][Full Text] [Related]
3. Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of IL-1 and IL-6.
Araki M; Yano T; Hayashi H; Takii T; Suzuki K; Onozaki K
Int J Cancer; 1994 Jan; 56(2):275-80. PubMed ID: 8314311
[TBL] [Abstract][Full Text] [Related]
4. Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse.
Hayashi H; Shimizu R; Fujii K; Itoh S; Yang D; Onozaki K
Int J Cancer; 1997 May; 71(3):416-21. PubMed ID: 9139878
[TBL] [Abstract][Full Text] [Related]
5. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
6. Transfection of human melanoma cells with type I interleukin-1 (IL-1) receptor cDNA rendered them IL-1-responsive and revealed the importance of ODC activity down-regulation in IL-1-induced growth inhibition.
Yang D; Hayashi H; Hiyama Y; Takii T; Onozaki K
J Biochem; 1995 Oct; 118(4):802-9. PubMed ID: 8576096
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of cytokine production by human malignant melanoma cells.
Armstrong CA; Tara DC; Hart CE; Köck A; Luger TA; Ansel JC
Exp Dermatol; 1992 Jul; 1(1):37-45. PubMed ID: 1344659
[TBL] [Abstract][Full Text] [Related]
8. Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alpha.
Wu S; Meeker WA; Wiener JR; Berchuck A; Bast RC; Boyer CM
Gynecol Oncol; 1994 Apr; 53(1):59-63. PubMed ID: 8175024
[TBL] [Abstract][Full Text] [Related]
9. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375.
Hattori T; Hayashi H; Chiba T; Onozaki K
Eur Cytokine Netw; 2001; 12(2):244-52. PubMed ID: 11399512
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of constitutive IL-1alpha gene expression in human melanoma cells: autocrine stimulation through NF-kappaB activation by endogenous IL-1alpha.
Kimura H; Inukai Y; Takii T; Furutani Y; Shibata Y; Hayashi H; Sakurada S; Okamoto T; Inoue J; Oomoto Y; Onozaki K
Cytokine; 1998 Nov; 10(11):872-9. PubMed ID: 9878124
[TBL] [Abstract][Full Text] [Related]
11. The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells.
Enya K; Hayashi H; Takii T; Ohoka N; Kanata S; Okamoto T; Onozaki K
J Leukoc Biol; 2008 Jan; 83(1):190-9. PubMed ID: 17906119
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hematopoietic growth factor production by genetically modified human bone marrow stromal cells expressing interleukin-1beta antisense RNA.
Hartwig UF; Keller U; Huber C; Peschel C
J Interferon Cytokine Res; 2001 Oct; 21(10):851-60. PubMed ID: 11710998
[TBL] [Abstract][Full Text] [Related]
13. CHOP, a basic leucine zipper transcriptional factor, contributes to the antiproliferative effect of IL-1 on A375 human melanoma cells through augmenting transcription of IL-6.
Hattori T; Itoh S; Hayashi H; Chiba T; Takii T; Yoshizaki K; Onozaki K
J Interferon Cytokine Res; 2001 May; 21(5):323-32. PubMed ID: 11429163
[TBL] [Abstract][Full Text] [Related]
14. MSH receptors and the response of human A375 melanoma cells to interleukin-1 beta.
Baumann JB; Bagutti C; Siegrist W; Christen E; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):199-210. PubMed ID: 9029491
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release.
Maragos CM; Wang JM; Hrabie JA; Oppenheim JJ; Keefer LK
Cancer Res; 1993 Feb; 53(3):564-8. PubMed ID: 8425188
[TBL] [Abstract][Full Text] [Related]
16. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
McDonald VL; Dick KO; Malik N; Shoyab M
Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation.
Hirose K; Longo DL; Oppenheim JJ; Matsushima K
FASEB J; 1993 Feb; 7(2):361-8. PubMed ID: 8440412
[TBL] [Abstract][Full Text] [Related]
18. Role of ornithine decarboxylase in the regulation of cell growth by IL-1 and tumor necrosis factor.
Endo Y; Matsushima K; Onozaki K; Oppenheim JJ
J Immunol; 1988 Oct; 141(7):2342-8. PubMed ID: 2971724
[TBL] [Abstract][Full Text] [Related]
19. Regulation of interleukin 8 expression in human malignant melanoma cells.
Singh RK; Varney ML
Cancer Res; 1998 Apr; 58(7):1532-7. PubMed ID: 9537260
[TBL] [Abstract][Full Text] [Related]
20. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
